Literature DB >> 15482919

Racemic and chiral lactams as potent, selective and functionally active CCR4 antagonists.

Bradley Newhouse1, Shelley Allen, Benjamin Fauber, Aaron S Anderson, C Todd Eary, Joshua D Hansen, Justin Schiro, John J Gaudino, Ellen Laird, David Chantry, Christine Eberhardt, Laurence E Burgess.   

Abstract

A series of racemic and chiral, nonracemic lactams that display high binding affinities, functional chemotaxis antagonism, and selectivity toward CCR4 are described. Compound 41, which provides reasonably high blood levels in mice when dosed intraperitoneally, was identified as a useful pharmacological tool to explore the role of CCR4 antagonism in animal models of allergic disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15482919     DOI: 10.1016/j.bmcl.2004.09.001

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  8 in total

1.  Effect of CC chemokine receptor 4 antagonism on the evolution of experimental autoimmune encephalomyelitis.

Authors:  Shivashankar Othy; Selma Topçu; Srini V Kaveri; Jagadeesh Bayry
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-03       Impact factor: 11.205

2.  Discovery of AZD-2098 and AZD-1678, Two Potent and Bioavailable CCR4 Receptor Antagonists.

Authors:  Nicholas Kindon; Glen Andrews; Andrew Baxter; David Cheshire; Paul Hemsley; Timothy Johnson; Yu-Zhen Liu; Dermot McGinnity; Mark McHale; Antonio Mete; James Reuberson; Bryan Roberts; John Steele; Barry Teobald; John Unitt; Deborah Vaughan; Iain Walters; Michael J Stocks
Journal:  ACS Med Chem Lett       Date:  2017-09-01       Impact factor: 4.345

3.  In silico identified CCR4 antagonists target regulatory T cells and exert adjuvant activity in vaccination.

Authors:  Jagadeesh Bayry; Elma Z Tchilian; Matthew N Davies; Emily K Forbes; Simon J Draper; Srini V Kaveri; Adrian V S Hill; Michel D Kazatchkine; Peter C L Beverley; Darren R Flower; David F Tough
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-11       Impact factor: 11.205

4.  Screening of chemokine receptor CCR4 antagonists by capillary zone electrophoresis.

Authors:  Zhe Sun; Lin-Jie Tian; Qian Lin; Xiao-Mei Ling; Jun-Hai Xiao; Ying Wang
Journal:  J Pharm Anal       Date:  2011-10-21

5.  Toward the discovery of vaccine adjuvants: coupling in silico screening and in vitro analysis of antagonist binding to human and mouse CCR4 receptors.

Authors:  Matthew N Davies; Jagadeesh Bayry; Elma Z Tchilian; Janakiraman Vani; Melkote S Shaila; Emily K Forbes; Simon J Draper; Peter C L Beverley; David F Tough; Darren R Flower
Journal:  PLoS One       Date:  2009-11-30       Impact factor: 3.240

6.  New drugs targeting Th2 lymphocytes in asthma.

Authors:  Gaetano Caramori; David Groneberg; Kazuhiro Ito; Paolo Casolari; Ian M Adcock; Alberto Papi
Journal:  J Occup Med Toxicol       Date:  2008-02-27       Impact factor: 2.646

7.  A new antagonist for CCR4 attenuates allergic lung inflammation in a mouse model of asthma.

Authors:  Yang Zhang; Yinfang Wu; Hui Qi; Junhai Xiao; Hongwei Gong; Yan Zhang; Enquan Xu; Song Li; Dalong Ma; Ying Wang; Wen Li; Huahao Shen
Journal:  Sci Rep       Date:  2017-11-08       Impact factor: 4.379

8.  Design and synthesis of a series of pyrido[2,3-d]pyrimidine derivatives as CCR4 antagonists.

Authors:  Hongwei Gong; Hui Qi; Wei Sun; Yang Zhang; Dan Jiang; Junhai Xiao; Xiaohong Yang; Ying Wang; Song Li
Journal:  Molecules       Date:  2012-08-20       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.